ADAPTIVE BIOTECHNOLOGIES CORPORATION Inventory Write-down
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Inventory Write-down of $2.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION inventory write-down for the quarter ending 2026-06-30 was $12.00K, a 78.18% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION inventory write-down for the quarter ending 2026-03-31 was -$10.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION inventory write-down for the quarter ending 2025-06-30 was $55.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION inventory write-down for the quarter ending 2025-03-31 was -$101.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION inventory write-down for fiscal 2025 was $563.00K, a 70.95% decline from fiscal 2024.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION inventory write-down for fiscal 2024 was $1.94M, a 39.73% increase from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION inventory write-down for fiscal 2023 was $1.39M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 12 month |
|---|---|---|---|
| 2026-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | -$10.00K 10-Q · filed 2026-05-05 | ||
| 2025-12-31 | $563.00K 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$46.00K 10-Q · filed 2026-08-04 | |
| 2025-03-31 | -$101.00K 10-Q · filed 2026-05-05 | ||
| 2024-12-31 | $1.94M 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $1.39M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |